The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation
Open accessAbstract
While the catalog of mammalian transcripts and their expression levels in different cell types and disease states is rapidly expanding, our understanding of transcript function lags behind. We present a robust technology enabling systematic investigation of the cellular consequences of repressing or inducing individual transcripts. We identify rules for specific targeting of transcriptional repressors (CRISPRi), typically achieving 90%-99% knockdown with minimal off-target effects, and activators (CRISPRa) to endogenous genes via endonuclease-deficient Cas9. Together they enable modulation of gene expression over a ∼1,000-fold range. Using these rules, we construct genome-scale CRISPRi and CRISPRa libraries, each of which we validate with two pooled screens. Growth-based screens identify essential genes, tumor suppressors, and regulators of differentiation. Screens for sensitivity to a cholera-diphtheria toxin provide broad insights into the mechanisms of pathogen entry, retrotranslocation and toxicity. Our results establish CRISPRi and CRISPRa as powerful tools that provide rich and complementary information for mapping complex pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Compared with gain-of-function perturbations, a higher proportion of loss-of-function perturbations yield phenotypes in growth and chemical-genetic screens, especially for members of protein complexes (Gilbert et al., 2014; Horlbeck et al., 2016).”
From Mapping information-rich genotype-phenotype landscapes with genome-scale Perturb-seq (2022) · cites this paper as Gilbert et al., 2014
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, CRISPRi (interference)23–25 and CRISPRa (activation)26–30 technologies utilize catalytically inactive Cas9 (dCas9) fused to either a transcriptional repressor (e.g., KRAB, Krüppel associated box) or a transcriptional activator (e.g., VPR, VP64-p65-Rta).”
From Large-scale CRISPR screening in primary human 3D gastric organoids enables comprehensive dissection of gene-drug interactions (2025) · cites this paper as [28]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Alternatives to DNA cleavage-induced editing include using CRISPR-Cas9 for direct chemical sequence alteration (base editing) 25,26 , providing RNA templates for gene alteration (prime editing) 27,28 , and for transcriptional control (CRISPR interference, CRISPRi; CRISPR activation, CRISPRa) 29,30 (Fig. 3).”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [30]
Experimental — accuracy not yet measuredIn the citing paper
“Pooling gene perturbations greatly improves scalability, but is not compatible with imaging of complex and dynamic cellular phenotypes.”
From Optical Pooled Screens in Human Cells (2019) · cites this paper as Gilbert et al., 2014
In the citing paper
“Striking examples are familial mutations causing neurodegenerative diseases, such as hereditary motor and sensory neuropathies (Charcot-Marie-Tooth disease), which can be caused by mutations in ubiquitously expressed trafficking factors (RAB7A, DNM2, DYNC1H1), or aminoacyl-tRNA synthetases (AARS, GARS, HARS, MARS)2.”
From Genome-wide CRISPRi/a screens in human neurons link lysosomal failure to ferroptosis (2021) · cites this paper as [2]
In the citing paper
“In addition to gene expression, gene function can also be cell type-specific, as evidenced by the fact that mutations in broadly expressed or housekeeping genes can lead to cell-type specific defects and disease states.”
From Genome-wide CRISPRi/a screens in human neurons link lysosomal failure to ferroptosis (2021) · cites this paper as [2]
In the citing paper
“CRISPRa evaluates gain-of-function phenotypes and can provide complementary insight to CRISPR knockout or CRISPRi-based loss-of-function screens42.”
From CRISPR-based functional genomics for neurological disease (2020) · cites this paper as [42]
In the citing paper
“CRISPRi-based gene knockdown may result in weaker phenotypes than full gene knockout, however it is non-toxic in iPSCs and iPSC-derived cells76, inducible76 and reversible42, thereby enabling time-resolved analysis of gene function76.”
From CRISPR-based functional genomics for neurological disease (2020) · cites this paper as [42]
In the citing paper
“CRISPRi represents an important advance over RNAi, since it lacks the pervasive off-target effects (Gilbert et al., 2014) inherent to RNAi-based screening approaches (Adamson et al., 2012; Jackson et al., 2003; Kaelin, 2012).”
From CRISPR Interference-Based Platform for Multimodal Genetic Screens in Human iPSC-Derived Neurons (2019) · cites this paper as Gilbert et al., 2014
In the citing paper
“Second, it is inducible and reversible (Gilbert et al., 2014)”
From CRISPR Interference-Based Platform for Multimodal Genetic Screens in Human iPSC-Derived Neurons (2019) · cites this paper as Gilbert et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.
Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn923 · Cited by 14,108
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
Genome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234
Landscape of transcription in human cells
Djebali, S., Davis, C. A., Merkel, A., Dobin, A., Lassmann, T., Mortazavi, A., Tanzer, A., Lagarde, J., Lin, W., Schlesinger, F., et al. (2012) · Nature · doi:10.1038/nature11233 · Cited by 5,187
Derrien, T., Johnson, R., Bussotti, G., Andrea Tanzer, A., Djebali, S., Tilgner, H., Guernec, G., Martin, D., Merkel, A., Knowles, D. G., et al. (2012) · Genome Research · doi:10.1101/gr.132159.111 · Cited by 5,135
Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., & Lim, W. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.022 · Cited by 5,016
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 901–1,000 of 1,008
CRISPR ‐Cas9 technology and its application in haematological disorders
Zhang, H., & McCarty, N. (2016) · British Journal of Haematology · doi:10.1111/bjh.14297 · Cited by 37
CRISPR–Cas9 Genetic Analysis of Virus–Host Interactions
Gebre, M. S., Nomburg, J., & Gewurz, B. E. (2018) · Viruses · doi:10.3390/v10020055 · Cited by 37
Development of an integrated CRISPRi targeting ΔNp63 for treatment of squamous cell carcinoma
Yoshida, M., Yokota, E., Sakuma, T., Yamatsuji, T., Takigawa, N., Ushijima, T., Yamamoto, T., Fukazawa, T., & Naomoto, Y. (2018) · Oncotarget · doi:10.18632/oncotarget.25678 · Cited by 36
Functional Interrogation of Primary Human T Cells via CRISPR Genetic Editing
Chen, X., Kozhaya, L., Taştan, C., Placek, L., Dogan, M., Horne, M., Abblett, R. L., Karhan, E., Vaeth, M., Feske, S., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701616 · Cited by 35
Sui, A., Yongbing, X., Yang, J., Pan, B., Wu, J., Guo, T., Shen, Y., & Guo, X. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.01.006 · Cited by 38
Cellular response to small molecules that selectively stall protein synthesis by the ribosome
Liaud, N., Horlbeck, M. A., Gilbert, L. A., Gjoni, K., Weissman, J. S., & Cate, J. H. D. (2019) · PLoS Genetics · doi:10.1371/journal.pgen.1008057 · Cited by 38
Self-citationTranslatable gene therapy for lung cancer using Crispr CAS9—an exploratory review
Nair, J., Nair, A., Veerappan, S., & Sen, D. (2019) · Cancer Gene Therapy · doi:10.1038/s41417-019-0116-8 · Cited by 36
Hazelbaker, D. Z., Beccard, A., Angelini, G., Mazzucato, P., Messana, A., Lam, D., Eggan, K. C., & Barrett, L. E. (2020) · Scientific Reports · doi:10.1038/s41598-020-57500-1 · Cited by 36
Nakatake, Y., Ko, S. B. H., Sharov, A. A., Wakabayashi, S., Murakami, M., Sakota, M., Chikazawa-Nohtomi, N., Ookura, C., Sato, S., Ito, N., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107655 · Cited by 34
Schilling, C., Koffas, M. A. G., Sieber, V., & Schmid, J. (2020) · ACS Synthetic Biology · doi:10.1021/acssynbio.0c00424 · Cited by 34
Identification of unrecognized host factors promoting HIV-1 latency
Li, Z., Hajian, C., & Greene, W. C. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1009055 · Cited by 36
CRISPR/Cas-Mediated Functional Gene Editing for Improvement in Bioremediation: An Emerging Strategy
Sahoo, S., Routray, S. P., Lenka, S., Bhuyan, R., & Mohanty, J. N. (2022) · Springer eBooks · doi:10.1007/978-981-19-4320-1_27 · Cited by 37
CRISPR-assisted transcription activation by phase-separation proteins
Liu, J., Chen, Y., Nong, B., Luo, X., Cui, K., Li, Z., Zhang, P., Tan, W., Yang, Y., Ma, W., et al. (2023) · Protein & Cell · doi:10.1093/procel/pwad013 · Cited by 37
Self-citationLi, J., Wu, S., Zhang, K., Sun, X., Lin, W., Wang, C., & Lin, S. (2024) · Microorganisms · doi:10.3390/microorganisms12010118 · Cited by 39
Epigenetic reprogramming shapes the cellular landscape of schwannoma
Liu, S. J., Casey-Clyde, T., Cho, N. W., Swinderman, J. T., Pekmezci, M., Dougherty, M. C., Foster, K. J., Chen, W., Villanueva-Meyer, J. E., Swaney, D. L., et al. (2024) · Nature Communications · doi:10.1038/s41467-023-40408-5 · Cited by 34
Self-citationCRISPR/Cas genome editing in soybean: challenges and new insights to overcome existing bottlenecks
Alves, N. S. F., Pinto, C. E. M., Távora, F. T. P. K., de Melo, B. P., Arraes, F. B. M., Lourenço‐Tessutti, I. T., de Moura, S. M., de Oliveira, A. C., Morgante, C. V., Qi, Y., et al. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.08.024 · Cited by 41
Gene therapy for genetic diseases: challenges and future directions
Beibei, Q. I. E., Tuo, J., Chen, F., Ding, H., & Lyu, L. (2025) · MedComm · doi:10.1002/mco2.70091 · Cited by 38
Sivanandan, S., Leitmann, B., Lubeck, E., Sultan, M. M., Stanitsas, P., Ranu, N., Ewer, A., Mancuso, J. E., Phillips, Z. F., Kim, A. M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66778-6 · Cited by 44
Taylor, J., & Woodcock, S. A. (2015) · SLAS DISCOVERY · doi:10.1177/1087057115590069 · Cited by 35
Re-engineered RNA-Guided FokI-Nucleases for Improved Genome Editing in Human Cells
Havlicek, S., Shen, Y., Alpagu, Y., Bruntraeger, M., Zufir, N. B. M., Phuah, Z. Y., Fu, Z., Dunn, N. R., & Stanton, L. W. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2016.11.007 · Cited by 33
Functional interrogation of non-coding DNA through CRISPR genome editing
Canver, M. C., Bauer, D. E., & Orkin, S. H. (2017) · Methods · doi:10.1016/j.ymeth.2017.03.008 · Cited by 36
One-Step piggyBac Transposon-Based CRISPR/Cas9 Activation of Multiple Genes
Li, S., Zhang, A., Xue, H., Li, D., & Liu, Y. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.06.007 · Cited by 35
CRISPR Genome Engineering for Human Pluripotent Stem Cell Research
Chaterji, S., Ahn, E. H., & Kim, D. (2017) · Theranostics · doi:10.7150/thno.18456 · Cited by 35
Split Cas9, Not Hairs − Advancing the Therapeutic Index of CRISPR Technology
Schmelas, C., & Grimm, D. (2018) · Biotechnology Journal · doi:10.1002/biot.201700432 · Cited by 35
Mini-review on current strategies to knockdown long non-coding RNAs
Behlke, M. A. (2016) · Journal of Rare Diseases Research & Treatment · doi:10.29245/2572-9411/2016/3.1066 · Cited by 36
Sanjurjo-Soriano, C., & Kalatzis, V. (2018) · Neural Plasticity · doi:10.1155/2018/5056279 · Cited by 38
Live-Cell Imaging of Chromatin Condensation Dynamics by CRISPR
Xue, Y., & Açar, M. (2018) · iScience · doi:10.1016/j.isci.2018.06.001 · Cited by 35
Mouse medulloblastoma driven by CRISPR activation of cellular Myc
Vo, B. T., Kwon, J. A., Li, C., Finkelstein, D., Xu, B., Orr, B. A., Sherr, C. J., & Roussel, M. F. (2018) · Scientific Reports · doi:10.1038/s41598-018-24956-1 · Cited by 36
Creation of versatile cloning platforms for transgene expression and dCas9-based epigenome editing
Haldeman, J. M., Conway, A. E., Arlotto, M. E., Slentz, D. H., Muoio, D. M., Becker, T. C., & Newgard, C. B. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky1286 · Cited by 34
CRISPulator: a discrete simulation tool for pooled genetic screens
Nagy, T. L., & Kampmann, M. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1759-9 · Cited by 32
Self-citationGeneration and validation of versatile inducible CRISPRi embryonic stem cell and mouse model
Li, R., Xia, X., Wang, X., Sun, X., Dai, Z., Huo, D., Zheng, H., Xiong, H., He, A., & Wu, X. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000749 · Cited by 35
Long non-coding RNAs in recurrent ovarian cancer: Theranostic perspectives
Bhardwaj, V., Tan, Y. Q., Wu, M., Ma, L., Zhu, T., Lobie, P. E., & Pandey, V. (2021) · Cancer Letters · doi:10.1016/j.canlet.2020.12.042 · Cited by 36
Verma, A. K., Tiwari, A., Lionetti, E., Srivastava, A., Monachesi, C., Catassi, G. N., Gatti, S., Galeazzi, T., & Catassi, C. (2021) · Foods · doi:10.3390/foods10102351 · Cited by 37
Development of Light‐Activated CRISPR Using Guide RNAs with Photocleavable Protectors
Jain, P., Ramanan, V., Schepers, A. G., Dalvie, N. S., Panda, A., Fleming, H. E., & Bhatia, S. N. (2016) · Angewandte Chemie · doi:10.1002/ange.201606123 · Cited by 35
Tutorial: design and execution of CRISPR in vivo screens
Braun, C. J., Adames, A. C., Saur, D., & Rad, R. (2022) · Nature Protocols · doi:10.1038/s41596-022-00700-y · Cited by 38
Competitive dCas9 binding as a mechanism for transcriptional control
Anderson, D. A., & Voigt, C. A. (2021) · Molecular Systems Biology · doi:10.15252/msb.202110512 · Cited by 36
Engineered smart materials for RNA based molecular therapy to treat Glioblastoma
Singh, R. R., Mondal, I., Janjua, T. I., Popat, A., & Kulshreshtha, R. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.11.007 · Cited by 36
Muthukumar, G., Stevens, T. A., Inglis, A. J., Esantsi, T. K., Saunders, R. A., Schulte, F., Voorhees, R. M., Guna, A., & Weissman, J. S. (2024) · Molecular Cell · doi:10.1016/j.molcel.2024.01.028 · Cited by 34
Self-citationMinev, T., Balbuena, S., Gill, J. M., Marincola, F. M., Kesari, S., & Lin, F. (2024) · Oncotarget · doi:10.18632/oncotarget.28672 · Cited by 34
Enzymatically Generated CRISPR Libraries for Genome Labeling and Screening
Lane, A. B., Strzelecka, M., Ettinger, A. W., Grenfell, A. W., Wittmann, T., & Heald, R. (2015) · Developmental Cell · doi:10.1016/j.devcel.2015.06.003 · Cited by 33
Development and potential applications of CRISPR-Cas9 genome editing technology in sarcoma
Liu, T., Shen, J. K., Li, Z., Choy, E., Hornicek, F. J., & Duan, Z. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.01.030 · Cited by 30
Tailor-made gene silencing of Staphylococcus aureus clinical isolates by CRISPR interference
Sato’o, Y., Hisatsune, J., Yu, L., Sakuma, T., Yamamoto, T., & Sugai, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0185987 · Cited by 34
Applications of the CRISPR/Cas system beyond gene editing
Anton, T., Karg, E., & Bultmann, S. (2018) · Biology Methods and Protocols · doi:10.1093/biomethods/bpy002 · Cited by 32
Genome Editing for CNS Disorders
Duarte, F. T., & Déglon, N. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.579062 · Cited by 36
Engineering a PAM-flexible SpdCas9 variant as a universal gene repressor
Wang, J., Teng, Y., Zhang, R., Wu, Y., Lou, L., Zou, Y., Li, M., Xie, Z., & Yan, Y. (2021) · Nature Communications · doi:10.1038/s41467-021-27290-9 · Cited by 35
Systematic functional interrogation of SARS-CoV-2 host factors using Perturb-seq
Sunshine, S., Puschnik, A. S., Replogle, J. M., Laurie, M. T., Liu, J., Zha, B. S., Nuñez, J. K., Byrum, J. R., McMorrow, A. H., Frieman, M. B., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41788-4 · Cited by 34
Self-citationTechnical considerations for the use of CRISPR/Cas9 in hematology research
Gundry, M. C., Dever, D. P., Yudovich, D., Bauer, D. E., Haas, S., Wilkinson, A. C., & Singbrant, S. (2017) · Experimental Hematology · doi:10.1016/j.exphem.2017.07.006 · Cited by 26
CRISPR applications in cancer diagnosis and treatment
Wang, M., Chen, M., Wu, X., Huang, X., & Yu, B. (2023) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-023-00483-4 · Cited by 36
Emerging Gene Therapeutics for Epidermolysis Bullosa under Development
Bischof, J., Hierl, M., & Koller, U. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042243 · Cited by 36
Harnessing artificial intelligence to advance CRISPR-based genome editing technologies
Thomson, T., Li, G. L., Strilchuk, A. W., Cui, H., Wang, B., & Li, B. (2025) · Nature Reviews Genetics · doi:10.1038/s41576-025-00907-1 · Cited by 34
Synthetic RNAs for Gene Regulation: Design Principles and Computational Tools
Laganà, A., Shasha, D. E., & Croce, C. M. (2014) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2014.00065 · Cited by 33
A genome editing primer for the hematologist
Hoban, M. D., & Bauer, D. E. (2016) · Blood · doi:10.1182/blood-2016-01-678151 · Cited by 32
Hough, S. H., Kancleris, K., Brody, L., Humphryes-Kirilov, N., Wolanski, J., Dunaway, K. W., Ajetunmobi, A., & Dillard, V. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1581-4 · Cited by 30
A Mixed-Effects Model for Powerful Association Tests in Integrative Functional Genomics
Su, Y., Di, C., Bien, S. A., Huang, L., Dong, X., Abecasis, G. R., Berndt, S. I., Bezieau, S., Brenner, H., Caan, B. J., et al. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.03.019 · Cited by 33
A Road Map to Personalizing Targeted Cancer Therapies Using Synthetic Lethality
Parameswaran, S., Kundapur, D., Vizeacoumar, F. S., Freywald, A., Uppalapati, M., & Vizeacoumar, F. J. (2018) · Trends in cancer · doi:10.1016/j.trecan.2018.11.001 · Cited by 34
Computational Methods for Mapping, Assembly and Quantification for Coding and Non-coding Transcripts
Babarinde, I. A., Li, Y., & Hutchins, A. P. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.04.012 · Cited by 30
Fauster, A., Rebsamen, M., Willmann, K. L., César‐Razquin, A., Girardi, E., Bigenzahn, J. W., Schischlik, F., Scorzoni, S., Brückner, M., Konecka, J., et al. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0192-6 · Cited by 34
Prediction of sgRNA on-target activity in bacteria by deep learning
Wang, L., & Zhang, J. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-3151-4 · Cited by 33
Application of CRISPR genetic screens to investigate neurological diseases
So, R. W. L., Chung, S., Lau, H. H. C., Watts, J. J., Gaudette, E. V., Al‐Azzawi, Z. A. M., Bishay, J., Lin, L. T., Joung, J., Wang, X., et al. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0343-3 · Cited by 37
CRISPR Interference–Potential Application in Retinal Disease
Peddle, C. F., Fry, L. E., McClements, M. E., & MacLaren, R. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072329 · Cited by 33
Lim, H., Jun, S., Park, M., Lim, J., Jeong, J., Lee, J. H., & Bang, D. (2020) · ACS Synthetic Biology · doi:10.1021/acssynbio.0c00002 · Cited by 33
The application of genome editing technology in fish
Lü, J., Fang, W., Huang, J., & Li, S. (2021) · Marine Life Science & Technology · doi:10.1007/s42995-021-00091-1 · Cited by 36
Building Endogenous Gene Connections through RNA Self-Assembly Controlled CRISPR/Cas9 Function
Lin, J., Wang, W., Wang, Y., Liu, Y., & Xu, L. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c09041 · Cited by 33
Park, H., & Kim, J. (2022) · Journal of Pineal Research · doi:10.1111/jpi.12787 · Cited by 33
The role of noncoding RNAs in metabolic reprogramming of cancer cells
Safi, A., Saberiyan, M., Sanaei, M., Adelian, S., Asl, F. D., Zeinaly, M., Shamsi, M., & Ahmadi, R. (2023) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-023-00447-8 · Cited by 36
Comparative landscape of genetic dependencies in human and chimpanzee stem cells
She, R., Fair, T., Schaefer, N. K., Saunders, R. A., Pavlovic, B. J., Weissman, J. S., & Pollen, A. A. (2023) · Cell · doi:10.1016/j.cell.2023.05.043 · Cited by 34
Self-citationIdentifying synthetic lethal targets using CRISPR/Cas9 system
Dhanjal, J. K., Radhakrishnan, N., & Sundar, D. (2017) · Methods · doi:10.1016/j.ymeth.2017.07.007 · Cited by 32
Advancing biotechnology with CRISPR/Cas9: recent applications and patent landscape
Ferreira, R., David, F., & Nielsen, J. (2018) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-017-2000-6 · Cited by 33
Psip1/p52 regulates posterior Hoxa genes through activation of lncRNA Hottip
Pradeepa, M. M., McKenna, F., Taylor, G. C. A., Bengani, H., Grimes, G. R., Wood, A. J., Bhatia, S., & Bickmore, W. A. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1006677 · Cited by 32
CRISPR Technologies in Chinese Hamster Ovary Cell Line Engineering
Glinšek, K., Bozovičar, K., & Bratkovič, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098144 · Cited by 35
Mitotic perturbation is a key mechanism of action of decitabine in myeloid tumor treatment
Yabushita, T., Chinen, T., Nishiyama, A., Asada, S., Shimura, R., Isobe, T., Yamamoto, K., Sato, N., Enomoto, Y., Tanaka, Y., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113098 · Cited by 32
Stress-free single-cell transcriptomic profiling and functional genomics of murine eosinophils
Borrelli, C., Gurtner, A., Arnold, I. C., & Moor, A. E. (2024) · Nature Protocols · doi:10.1038/s41596-024-00967-3 · Cited by 34
Yin, J., Frick, L. D., Scheidmann, M. C., Liu, T., Trevisan, C., Dhingra, A., Spinelli, A., Wu, Y., Yao, L., Vena, D. L., et al. (2024) · Nature Biomedical Engineering · doi:10.1038/s41551-024-01278-4 · Cited by 55
Self-citationSynthetic Biology—Toward Therapeutic Solutions
Haellman, V., & Fussenegger, M. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.08.020 · Cited by 34
Prioritising Causal Genes at Type 2 Diabetes Risk Loci
Grotz, A. K., Gloyn, A. L., & Thomsen, S. K. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0907-y · Cited by 32
CRISPRi is not strand-specific at all loci and redefines the transcriptional landscape
Howe, F. S., Russell, A. J. C., Lamstaes, A. R., El-Sagheer, A. H., Nair, A., Brown, T. P., & Mellor, J. (2017) · eLife · doi:10.7554/elife.29878 · Cited by 32
Targeted DNA transposition in vitro using a dCas9-transposase fusion protein
Bhatt, S., & Chalmers, R. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz552 · Cited by 32
Plant gene expression control using genome- and epigenome-editing technologies
Miglani, G. S., Kaur, A., & Kaur, L. (2019) · Journal of Crop Improvement · doi:10.1080/15427528.2019.1678541 · Cited by 33
Programming PAM antennae for efficient CRISPR-Cas9 DNA editing
Wang, F., Hao, Y., Li, Q., Li, J., Zhang, H., Zhang, X., Wang, L., Bustamante, C., & Fan, C. (2020) · Science Advances · doi:10.1126/sciadv.aay9948 · Cited by 33
FOXO1 promotes HIV latency by suppressing ER stress in T cells
Vallejo-Gracia, A., Chen, I. P., Perrone, R., Besnard, E., Boehm, D., Battivelli, E., Tezil, T., Krey, K., Raymond, K. A., Hull, P. A., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0742-9 · Cited by 32
Dong, C., Jiang, L., Xu, S., Huang, L., Cai, J., Lian, J., & Xu, Z. (2020) · ACS Synthetic Biology · doi:10.1021/acssynbio.0c00218 · Cited by 32
CRISPRi screens reveal genes modulating yeast growth in lignocellulose hydrolysate
Gutmann, F., Jann, C., Pereira, F. M., Johansson, A., Steinmetz, L. M., & Patil, K. R. (2021) · Biotechnology for Biofuels · doi:10.1186/s13068-021-01880-7 · Cited by 31
CRISPR screen in cancer: status quo and future perspectives.
He, C., Han, S., Chang, Y., Wu, M., Zhao, Y., Chen, C. Y., & Chu, X. (2021) · PubMed · Cited by 37
CRISPR-Cas Technology: Emerging Applications in Clinical Microbiology and Infectious Diseases
Serajian, S., Ahmadpour, E., Oliveira, S. M. R., Pereira, M. D. L., & Heidarzadeh, S. (2021) · Pharmaceuticals · doi:10.3390/ph14111171 · Cited by 35
CasTuner is a degron and CRISPR/Cas-based toolkit for analog tuning of endogenous gene expression
Noviello, G., Gjaltema, R. A. F., & Schulz, E. G. (2023) · Nature Communications · doi:10.1038/s41467-023-38909-4 · Cited by 32
The CRISPR/Cas9 system for gene editing and its potential application in pain research
Sun, L., Marie, L. B., & Yuan-Xiang, T. (2016) · Translational Perioperative and Pain Medicine · doi:10.31480/2330-4871/040 · Cited by 32
Bennett, N. K., Lee, M., Orr, A. L., & Nakamura, K. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2307904121 · Cited by 32
Spastin locally amplifies microtubule dynamics to pattern the axon for presynaptic cargo delivery
Aiken, J., & Holzbaur, E. L. F. (2024) · Current Biology · doi:10.1016/j.cub.2024.03.010 · Cited by 31
Shin, T., Song, J. H. T., Kosicki, M., Kenny, C. J., Beck, S. G., Kelley, L., Antony, I., Qian, X., Bonacina, J., Papandile, F., et al. (2024) · Cell Genomics · doi:10.1016/j.xgen.2024.100609 · Cited by 33
The rise and future of CRISPR-based approaches for high-throughput genomics
Vercauteren, S., Fiesack, S., Maroc, L., Verstraeten, N., Dewachter, L., Michiels, J. J., & Vonesch, S. C. (2024) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuae020 · Cited by 35
LINE1 and PRC2 control nucleolar organization and repression of the 8C state in human ESCs
Zhang, J., Ataei, L., Mittal, K., Wu, L. L., Caldwell, L., Huynh, L., Sarajideen, S., Tse, K. Y., Simon, M.-M., Mazid, M. A., et al. (2024) · Developmental Cell · doi:10.1016/j.devcel.2024.09.024 · Cited by 34
Application of the CRISPR gene‐editing technique in insect functional genome studies – a review
Cui, Y., Sun, J., & Yu, L. (2017) · Entomologia Experimentalis et Applicata · doi:10.1111/eea.12530 · Cited by 31
Lyon, K., & Stasevich, T. J. (2017) · Trends in Genetics · doi:10.1016/j.tig.2017.02.003 · Cited by 31
A permutation-based non-parametric analysis of CRISPR screen data
Jia, G., Wang, X., & Xiao, G. (2017) · BMC Genomics · doi:10.1186/s12864-017-3938-5 · Cited by 32
Disruptive Technology: CRISPR/Cas-Based Tools and Approaches
Patsali, P., Kleanthous, M., & Lederer, C. W. (2019) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-019-00391-4 · Cited by 31
Effective CRISPR interference of an endogenous gene via a single transgene in mice
MacLeod, R. S., Cawley, K. M., Gubrij, I. B., Nookaew, I., Onal, M., & O’Brien, C. A. (2019) · Scientific Reports · doi:10.1038/s41598-019-53611-6 · Cited by 31
Efficient Genome Editing in Multiple Salmonid Cell Lines Using Ribonucleoprotein Complexes
Gratacap, R. L., Jin, Y., Mantsopoulou, M., & Houston, R. D. (2020) · Marine Biotechnology · doi:10.1007/s10126-020-09995-y · Cited by 31
Li, L., Gao, Y., Srivastava, R., Wang, W., Xiong, Q., Fang, Z., Pelayo, A., Denson, C. R., Goswami, A., Harari-Steinfeld, R., et al. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02526-2 · Cited by 30
Self-citationCRISPR-Cas System: The Powerful Modulator of Accessory Genomes in Prokaryotes
Butiuc-Keul, A. L., Farkas, A., Carpa, R., & Iordache, D. (2021) · Microbial Physiology · doi:10.1159/000516643 · Cited by 31
Contextual Reprogramming of CAR-T Cells for Treatment of HER2+ Cancers
Yang, Z., Li, L., Turkoz, A., Chen, P., Harari-Steinfeld, R., Bobbin, M. L., Stefanson, O., Choi, H., Pietrobon, V., Alphson, B., et al. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-021-03132-6 · Cited by 32
Self-citation
Metadata
- Authors
- Gilbert, L. A., Horlbeck, M. A., Adamson, B., Villalta, J. E., Chen, Y., Whitehead, E. H., Guimaraes, C., Panning, B., Ploegh, H. L., Bassik, M. C., Qi, L. S., Kampmann, M., & Weissman, J. S.
- Affiliations
- QB3 (US)
- University of California, San Francisco (US)
- Whitehead Institute for Biomedical Research (US)
- Corresponding author
- Kampmann, Martin
- Weissman, Jonathan S.
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2014-10
- Volume
- 159
- Issue
- 3
- Pages
- 647-661
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC4253859
- OpenAlex
- W2152505144
- Cited by
- 2,728
- References
- 60
- Citations by year
- 2026: 190 · 2025: 211 · 2024: 265 · 2023: 212 · 2022: 261 · 2021: 285 · 2020: 285 · 2019: 255 · 2018: 221 · 2017: 214 · 2016: 182 · 2015: 125 · 2014: 14
- FWCI
- 73.17
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-nd)
- eScholarship (California Digital Library) (submittedVersion)
- PMC
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health (DP5OD017887, 1dp2hd084069-01)
- National Institute on Aging (P01AG010770)
- National Institute on Drug Abuse (R01DA036858)
- National Cancer Institute (K99CA181494, U01CA168370)
- National Institute of General Medical Sciences (T32GM008284, P50GM081879, R01GM100341, P50GM102706, R01GM100518)
- National Institute of Biomedical Imaging and Bioengineering (T32EB009383)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- CRISPR interference, CRISPR activation, transcriptional repression, transcriptional activation, gene essentiality, tumor suppressor, cholera toxin, diphtheria toxin, pathogen entry, retrotranslocation, off-target effects
- MeSH terms
- Cell Line, Cholera Toxin, Diphtheria Toxin, Genetic Techniques, Humans, Transcription, Genetic, Genome, Human, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
